VANI
Vivani Medical, Inc.
NASDAQ · USHealthcareMedical - Devices
$1.35+2.27%
Price as of Jul 20, 2026
VANI financials
Vivani Medical, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of revenue | $424.0K | $0.00 | $357.0K | $0.00 |
| Gross profit | -$424.0K | $0.00 | -$357.0K | $0.00 |
| Operating expenses | $27.1M | $24.7M | $26.6M | $21.2M |
| Operating income | -$27.6M | -$24.7M | -$27.0M | -$21.2M |
| Net income | -$26.6M | -$23.5M | -$25.7M | -$13.9M |
| EBITDA | -$26.2M | -$23.1M | -$25.3M | -$19.2M |
| Basic EPS | $-0.43 | $-0.43 | $-0.50 | $-0.17 |
| Diluted EPS | $-0.43 | $-0.43 | $-0.50 | $-0.17 |
| Balance sheet | ||||
| Cash & equivalents | $16.2M | $18.4M | $20.7M | $45.1M |
| Total assets | $39.4M | $41.6M | $45.8M | $51.1M |
| Total liabilities | $23.7M | $24.0M | $25.0M | $6.8M |
| Stockholders’ equity | $15.7M | $17.6M | $20.8M | $44.3M |
| Total debt | $18.9M | $19.3M | $20.7M | $955.0K |
| Net debt | $2.6M | $961.0K | $42.0K | -$44.1M |
| Cash flow | ||||
| Operating cash flow | -$24.3M | -$20.8M | -$23.7M | -$18.8M |
| Capital expenditure | -$1.2M | -$556.0K | -$887.0K | -$338.0K |
| Free cash flow | -$25.5M | -$21.3M | -$24.6M | -$19.1M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | -$28.0K | $0.00 | $0.00 | $0.00 |